Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis

NCT00043264 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Rifampin
DRUG: Azithromycin

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]